Poison Ivy, Oak and Sumac — Oh My!
[ad_1] (RxWiki News) If you are spending time outdoors this summer, you may come into contact with poison ivy, poison oak or poison sumac. Here’s what you need to know.
Mole or Melanoma? | RxWiki
[ad_1] (RxWiki News) Some adults can have up to 40 moles. But when should you start worrying about skin cancer? Although it’s relatively rare, a common mole can turn into
New Treatment Option for Plaque Psoriasis
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) recently approved a new treatment option for adults with moderate to severe plaque psoriasis. This newly approved drug is called
Several New Medications Approved | RxWiki
[ad_1] (RxWiki News) As a new year begins, we celebrate the beginning of something new and exciting. This year, that includes several new medication approvals from the US Food and
Options for Eczema | RxWiki
[ad_1] (RxWiki News) Many adults with eczema may be missing out on new treatments for the condition, according to a new report. This new report noted that many adults who
Inflammatory Disease Rx Gets Green Light
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases. This new approval is found under the brand name
These Cosmetics May Be Harmful
[ad_1] These Cosmetics May Be Harmful (RxWiki News) Check your cabinet for these recently recalled cosmetics. The US Food and Drug Administration (FDA) has issued recalls on the following products
The Dangers of Dermal Fillers
[ad_1] (RxWiki News) You may be getting more than you bargained for with dermal fillers, according to the US Food and Drug Administration (FDA). The FDA is warning both consumers
Another Biosimilar Gets a Green Light
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system. This new approval is Renflexis
There’s a New Rx for Eczema
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat eczema. Dupixent (dupilumab) was approved for use in adults and is to be